The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, November 15, 2017
The MDA announced 13 new research and development grants totaling $3.5 million to accelerate development of treatments for muscular dystrophy, ALS, ...
read more
Wednesday, November 15, 2017
Biohaven reported financial results for the quarter ended September 30, 2017, and provided a review of recent accomplishments and anticipated upcoming...
read more
Tuesday, November 14, 2017
Bayer has entered into an exclusive global collaboration with Loxo Oncology for the development and commercialization of larotrectinib.
read more
Tuesday, November 14, 2017
Debiopharm announced the EMA granted Orphan Drug Designation to Debio 1347 for treatment of Biliary Tract Cancer.
read more
Tuesday, November 14, 2017
Monopar Therapeutics announced the acquisition of GPX-150 from privately held Gem Pharmaceuticals concurrent with $9.7 million of new financing.
read more
Monday, November 13, 2017
Merck announced the CHMP of the European Medicines Agency has adopted a positive opinion recommending approval of PREVYMIS
read more
Monday, November 13, 2017
Theravance Biopharma and Mylan N.V. announced the submission of an NDA to the FDA for revefenacin (TD-4208).
read more
Monday, November 13, 2017
Alnylam announced the CHMP of the EMA has granted an accelerated assessment for patisiran.
read more
Friday, November 10, 2017
Blueprint Medicines announced Phase 1 clinical data for BLU-285 for patients with advanced gastrointestinal stromal tumors.
read more
Thursday, November 09, 2017
Neurimmune has entered into a collaboration with Ono Pharmaceutical focused on the development of human antibodies against a novel therapeutic target ...
read more
Wednesday, November 08, 2017
OncoSec announced positive updated long-term follow-up data from its Phase 2 OMS I-102 combination study of ImmunoPulse IL-12 and pembrolizumab.
read more
Wednesday, November 08, 2017
Astellas and Seattle Genetics announced dosing of the first patient in EV-103.
read more
Monday, November 06, 2017
Artemis announced that the FDA granted orphan drug designation for Artemisone, the company's lead product candidate, for the treatment of malaria.
read more
Monday, November 06, 2017
Biohaven announced the first subject was dosed in its bioequivalence study designed to demonstrate the pharmacokinetic equivalence of sublingual BHV-...
read more
Monday, November 06, 2017
Stealth announced the initiation of MMPOWER-3, a Phase 3 study evaluating the efficacy and safety of daily subcutaneous injections of elamipretide in ...
read more